Rujiao Dong

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Wenzhou Medical University(Current)

First Affiliated Hospital of Wenzhou Medical University

Rujiao Dong is an author at Wenzhou Medical University specializing in t-cell therapy, hematologic malignancy car t-cell therapy, and car t cell trials.

ORCID

Publications per year

2021–2023

Publications

The correlation factors and prognostic significance of coagulation disorders after chimeric antigen receptor T cell therapy in hematological malignancies: a cohort study

Rujiao Dong, Yudi Wang, Yuanyuan Lin et al. · Annals of Translational Medicine · 2022 · 19 citations · Full text

Medicine, Hematology, Immunology +17

Prognostic Significance of Cytokine Release Syndrome in B Cell Hematological Malignancies Patients After Chimeric Antigen Receptor T Cell Therapy

Rujiao Dong, Songfu Jiang, Yi Chen et al. · Journal of Interferon & Cytokine Research · 2021 · 16 citations

Medicine, Hematology, Oncology +16

Identification and validation of a novel cuproptosis-related gene signature in multiple myeloma

Bingxin Zhang, Quanqiang Wang, Tianyu Zhang et al. · Frontiers in Cell and Developmental Biology · 2023 · 14 citations · Full text

Medicine, Hematology, Pathology +12

Interaction between CD9 and PI3K‑p85 activates the PI3K/AKT signaling pathway in B‑lineage acute lymphoblastic leukemia

Yifen Shi, Ziyang Huang, Yisha Huang et al. · Oncology Reports · 2021 · 12 citations · Full text

Medicine, Oncology, Pharmacology +17

1–4 of 4